Our findings identified for the first time a key role of GPR26 in energy homeostasis, suggesting that targeting GPR26 with chemical compounds may provide a novel treatment for obesity thought modulation of appetite. The gene discussed is GPR26; the disease is obesity due to melanocortin 4 receptor deficiency.